Peripheral T-cell lymphoma
Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma
... PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; ALCL, anaplastic large cell lymphoma; AITL, angioimmunoblastic T-cell lymphoma; ECOG, Eastern ...
5
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
... Abstract: T-cell lymphoma is a rare hematologic malignancy with an incidence rate between 10% and 20% of that of non-Hodgkin ...with peripheral T-cell lymphoma (PTCL) ...
7
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
... The efficacy and safety of chidamide, a new subtype-selective histone deacetylase (HDAC) inhibitor, have been demonstrated in a pivotal phase II clinical trial, and chidamide has been approved by the China Food and Drug ...
5
Peripheral T cell lymphoma: clinical utility of romidepsin
... patients’ peripheral mononuclear ...with peripheral T cell lymphoma was declared to be in complete remission after the eighth cycle of ...in T cell lymphoma and ...
7
GATA3 expression correlates with poor prognosis and tumor- associated macrophage infiltration in peripheral T cell lymphoma
... Peripheral T cell lymphoma (PTCL), which is common in Asia [1], is an aggressive form of lymphoma associated with poor patient ...defined T-cell lymphoma ...
11
Case Report Peripheral T cell lymphoma, not otherwise specified with myelofibrosis : report of a case with review of the literature
... Abstract: A 68-year-old man presented to us with pancytopenia, erythroderma, and multiple lymphadenopa- thies. Lymph node biopsy led to the diagnosis of peripheral T-Cell lymphoma-not ...
18
Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process
... of T-cell gene rearrangements, although PCR analysis has not shown monoclonality in all ...developed peripheral T-cell lymphoma ...
5
Sustained Remission with Mogamulizumab in Peripheral T Cell Lymphoma with Aberrant CD20 Expression: Case Report and Literature Review
... [7] d’Amore, F., Relander, T., Lauritzsen, G.F., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U.M., Gadeberg, O.V., ...
9
<p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>
... All studies on PTCL therapeutic regimens performed with CHOP and CHOPE were searched using several major databases including PubMed, Embase, Wanfang, and CNKI with the search terms “(peripheral ...
8
Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report
... Peripheral T-cell lymphomas not otherwise specified are generally considered aggressive non-Hodgkin lymphomas, because of poor natural outcome and response to ...of peripheral ...
7
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
... Abstract: Peripheral T cell lymphoma (PTCL) has a poor ...angioimmunoblastic T cell lymphoma (AITL) patients compared to only ...
7
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
... Aggressive T cell lymphomas are a subgroup of lymphomas with a particularly poor ...against T cell ...refractory peripheral T cell ...
8
Clinical Pathological Features of Peripheral T Cell Lymphoma with Concurrent Bone Marrow Involvement
... Abstract: Peripheral T cell lymphomas (PTCLs) are uncommon and less well ...nodal peripheral T cell lymphoma and subsequent bone marrow biopsy positive for the same ...of ...
5
Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy
... Copyright © 2010 Li-Jun Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
5
Therapeutic options in peripheral T cell lymphoma
... Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor ...anaplastic lymphoma kinase (ALK)-positive anaplastic large cell ...
10
Chidamide in the treatment of peripheral T-cell lymphoma
... mature T-cell lymphomas, the most common subtypes include peripheral T-cell lymphoma, not otherwise specified, angioimmunoblastic T-cell lymphoma (AITL), and ...
6
BELINOSTAT: A HISTONE DEACETYLASE INHIBITOR FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA
... refractory peripheral T- cell lymphoma 18 ...refractory peripheral T-cell lymphoma, who did not obtain enhanced after handling with extra drugs or whose cancer came ...
9
An update on the management of peripheral T-cell lymphoma and emerging treatment options
... Peripheral T-cell lymphomas (PTCLs) are a subset of non-Hodgkin’s lymphomas (NHLs) that arise from lymphocytes at the post-thymic stage of maturation, which display T-cell or natural ...
11
Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T cell lymphoma: a case report
... of peripheral T-cell lymphoma (PTCL) was made based on the T-cell receptor rearrange- ment seen in the tumor cells of his brain ...
7
New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
... measurable lymphoma manifestation, thrombocyte counts of $50,000/ µ L, absence of prior HDACi therapy, adequate organ function, and no relapse following autoSCT or alloSCT within 100 ...
7